Machine learning to predict post-therapy dosimetry for 177Lu-PSMA I&T treatment

被引：0
|
作者：
Shi, K. [1 ]
Xue, S. [1 ]
Gafita, A. [2 ]
Dong, C. [2 ]
Zhao, Y. [2 ]
Tetteh, G. [2 ]
Menze, B. H. [2 ]
Afshar-Oromieh, A. [1 ]
Eiber, M. [2 ]
Rominger, A. [1 ]
机构：
[1] Univ Bern, Bern, Switzerland
[2] Tech Univ Munich, Munich, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2019年 / 46卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-441
引用
收藏
页码：S170 / S170
页数：1
相关论文
共 50 条
  • [1] Artificial Neural Network for Prediction of Post-therapy Dosimetry for 177Lu-PSMA I&T Therapy
    Shi, Kuangyu
    Dong, Chao
    Gafita, Andrei
    Zhao, Yu
    Tetteh, Giles
    Menze, Bjoern
    Afshar-Oromieh, Ali
    Eiber, Matthias
    Rominger, Axel
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [2] Voxel-wise Prediction of Post-therapy Dosimetry for 177Lu-PSMA I&T Therapyusing Deep Learning
    Xue, S.
    Gafita, A.
    Zhao, Y.
    Afshar-Oromieh, A.
    Eiber, M.
    Rominger, A.
    Shi, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S237 - S238
  • [3] Voxel-wise Prediction of Post-therapy Dosimetry for 177Lu-PSMA I&T Therapy using Deep Learning
    Xue, Song
    Gafita, Andrei
    Afshar-Oromieh, Ali
    Eiber, Matthias
    Rominger, Axel
    Shi, Kuangyu
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [4] Application of machine learning to pretherapeutically estimate dosimetry in men with advanced prostate cancer treated with 177Lu-PSMA I&T therapy
    Xue, Song
    Gafita, Andrei
    Dong, Chao
    Zhao, Yu
    Tetteh, Giles
    Menze, Bjoern H.
    Ziegler, Sibylle
    Weber, Wolfgang
    Afshar-Oromieh, Ali
    Rominger, Axel
    Eiber, Matthias
    Shi, Kuangyu
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (12) : 4064 - 4072
  • [5] Application of machine learning to pretherapeutically estimate dosimetry in men with advanced prostate cancer treated with 177Lu-PSMA I&T therapy
    Song Xue
    Andrei Gafita
    Chao Dong
    Yu Zhao
    Giles Tetteh
    Bjoern H. Menze
    Sibylle Ziegler
    Wolfgang Weber
    Ali Afshar-Oromieh
    Axel Rominger
    Matthias Eiber
    Kuangyu Shi
    European Journal of Nuclear Medicine and Molecular Imaging, 2022, 49 : 4064 - 4072
  • [6] Patient dosimetry of 177Lu-PSMA I&T in metastatic prostate cancer treatment: the experience in Thailand
    Kotchakorn Chatachot
    Shuichi Shiratori
    Tawatchai Chaiwatanarat
    Kitiwat Khamwan
    Annals of Nuclear Medicine, 2021, 35 : 1193 - 1202
  • [7] Patient dosimetry of 177Lu-PSMA I&T in metastatic prostate cancer treatment: the experience in Thailand
    Chatachot, Kotchakorn
    Shiratori, Shuichi
    Chaiwatanarat, Tawatchai
    Khamwan, Kitiwat
    ANNALS OF NUCLEAR MEDICINE, 2021, 35 (11) : 1193 - 1202
  • [8] Comparative preclinical biodistribution, dosimetry and endoradiotherapy in mCRPC of 177Lu-rhPSMA-7.3 and 177Lu-PSMA I&T
    Yusufi, N.
    Nekolla, S.
    Wurzer, A.
    Herz, M.
    D'Alessandria, C.
    Weber, W.
    Wester, H. J.
    Eiber, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S642 - S643
  • [9] Radiochemical Stability of therapeutic radiopharmaceutical of 177Lu-PSMA I&T
    Chandrashekar, R.
    Fagan, J.
    Lim, R.
    Vyas, M.
    INTERNAL MEDICINE JOURNAL, 2022, 52 : 41 - 41
  • [10] PBPK Model Based Voxel-wise Prediction of Posttherapy Dosimetry for 177Lu-PSMA I&T Therapy
    Xue, S.
    Gafita, A.
    Drobnjakovic, M.
    Zhao, Y.
    Birindelli, G.
    Afshar-Oromieh, A.
    Eiber, M.
    Rominger, A.
    Shi, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S345 - S346
12345